Myomectomy Market – An Immortal Market with a Stunning CAGR of ~6.9% by 2023

“Market Research Future (MRFR)”
The report titled “Myomectomy Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Myomectomy Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global myomectomy market is expected to grow at a CAGR of 6.9% du adds “Myomectomy Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

Market Scenario of Global Myomectomy Market:

Myomectomy a surgical procedure for the removal uterine fibroids. Uterine fibroids are common noncancerous growth in the uterus of women at their child bearing age, causing symptoms such as heavy bleeding during menstrual cycle, increased menstrual cramping, pain in pelvis or lower back, and swelling enlargement of the abdomen. Myomectomy differs from hysterectomy. During myomectomy, the surgeons remove only the fibroids in the uterus while in hysterectomy entire uterus is removed. This procedure preserves the chances of women getting pregnant. There are four types of myomectomy namely; abdominal, hysteroscopic, laparoscopic, and robotic. Results of myomectomy are found to be better and women report improvement in fibroid symptoms, such as heavy menstrual bleeding and pelvic pressure.

Rising prevalence of uterine fibroids, and increasing demand for diagnosis and treatment of uterine disorder. Additionally, increasing demand for medical devices for gynecology procedures also fuel the growth of the market. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Splendid research in the field of reproductive health and diseases also boost the market.

The growth of medical device industry and increasing demand for technological advanced medical devices also fuels the growth of the market across the globe. However, the growth of the market is restricted due to increasing competition among existing players and high cost of medical devices.

According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s. Not all women with fibroids have symptoms; nearly 45% to 50% of the women do not exhibit symptoms in their lifespan. Increase in the age also affect the prevalence rate of uterine fibroids.

Key Players for Global Myomectomy Market:

Some of the key players in this market are Halt Medical, Inc. (U.K), Boston Scientific Corporation (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), General Electric Company (U.S.), KARL STORZ SE & Co. KG (Germany), Richard Wolf Medical Instruments (U.S.), Siemens (U.S.), AbbVie Inc. (U.S.), Bayer (Germany), Eli Lilly and Company (U.S.), Johnson & Johnson Services Inc. (U.S.) and others.

Segmentation of Global Myomectomy Market:

The global myomectomy market is segmented on the basis of type, product, and end user.

On the basis of type, market is segmented into abdominal, hysteroscopic, laparoscopic, and robotic.

On the basis of product, the market is segmented into laparoscopic power morcellators, harmonic scalpel, laparoscopic sealer, and others.

On the basis of end user, the market is segmented into hospitals & clinics, surgical centers, medical device companies, and others.


Regional Analysis of Global Myomectomy Market:

America holds the first position in the market for myomectomy owing to the rising prevalence of uterine disorders in the U.S., and increasing demand for new diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare IT industry.  Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.

Europe is the second largest market for myomectomy. In Europe, there is an increasing demand for medical devices and availability of funds for research and development activities in the reproductive health. The growth of surgical devices in Germany, France, and U.K also fuels the growth of the market.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing women suffering from uterine disorders, and rising investment in surgical device industry by key players in developing economies throughout Asia Pacific. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand technologically advanced medical devices such as gene chips for research activities, and availability of highly qualified medical professional such as surgeons and gynecologists.

The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about diagnosis and treatment of uterine fibroids. In the Middle East & Africa, Middle East captures the largest market share for myomectomy owing to the availability of better healthcare infrastructure, availability of specialty services and wide scope for research.

Major TOC of Myomectomy Market:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Myomectomy Market, By Type

Chapter 7. Global Myomectomy Market, By Product

Chapter 8. Global Myomectomy Market, By End User

Chapter 9. Global Myomectomy Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion



About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India